The Maplewood-based company announced in 2022 it would cease producing using the “forever chemical” in the span of three years, though it still expects to use third-party PFAS in some products.
The ComfortMode is part of new CEO Linda Findley’s turnaround plan for the Minneapolis company. She said the mattress appeals to a broader consumer base.
Celcuity, a clinical-stage company developing a cancer drug, had promising clinical trials. Among Minnesota’s public companies, half saw their stock increase this year.